“…Cells were subsequently cultured in fresh serum-deprived medium (0.5% foetal bovine serum) supplemented with either TGF-b 1 Sigma-Aldrich) (5 ng/mL), anti-TGF-b 1 (R&D Systems, Minneapolis, MN, USA) (10 lg/mL), shikonin 1 lM (TCI Europe, Zwijndrecht, Belgium), shikonin 1 lM + anti-TGF-b 1 (10 lg/mL), asiaticoside 15.6 lM (Sigma-Aldrich), dexamethasone 10 lM (Sigma-Aldrich) or left untreated (blank). We use asiaticoside as a positive standard because it has a long history of use for treating skin and vascular diseases in Asia, and has recently been demonstrated to increase wound healing in vitro through an increase in cell migration (Lee et al, 2012). The migration of the cells across the wound line was assessed 24 h later in a blind fashion with the aid of ImageJ software for Mac OS X (US National Institutes of Health) (Bu et al, 2007).…”